Latest Asx Trading News

Amaero Ltd has obtained Federal Court approval to re-domicile to Delaware via schemes exchanging Australian shares and options for US HoldCo equivalents, marking a major structural shift.

Antilles Gold’s Cuban joint venture Minera La Victoria has been hit with US sanctions, prompting a suspension of the company’s direct involvement and halting trading of its shares and options.

The Supreme Court of Western Australia has approved Genesis Minerals’ acquisition of Magnetic Resources, setting a clear timetable for scheme implementation and ASX trading suspension.

Hartshead Resources held a pivotal scheme meeting on 8 June 2026 to approve ACAM GP Limited’s acquisition offer, featuring a 133% premium and unanimous board support. The outcome now hinges on final court approval.

The Supreme Court of New South Wales has approved schemes of arrangement that transfer Nova Minerals' ownership to a new US holding company, with ASX trading set to suspend immediately.

Opthea Limited resumes ASX trading as it pivots to develop OPT-302 for lymphangioleiomyomatosis, outlining a disciplined 18-month staged clinical program backed by A$31.2 million in cash.

Corporate Travel Management reports progress on UK customer remediation with funding plans underway and final agreements near completion. The company maintains strong client retention above 97% and aims to release audited FY25 and reviewed 1H26 financials by end of June, eyeing a swift return to ASX trading.

Nova Minerals shareholders and Nasdaq warrantholders overwhelmingly approved schemes to restructure the company under a new US holding entity, pending final court approval.

Elanor Investors Group has called off its planned acquisition of Singapore-based Firmus Capital due to prolonged regulatory delays, while reaffirming its $125 million recapitalisation with Rockworth Capital Partners and seeking ASX trading reinstatement.

Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.

Straker Limited resumes ASX trading after suspending shares due to transaction anomalies at its US subsidiary. The company maintains normal operations while cooperating with US authorities.

5E Advanced Materials has requested suspension of its shares from ASX trading to enable its removal from the official list, marking a significant shift in its market presence.